Case Studies

These case studies are anonymized composites drawn from observed patterns across enterprise AI programs. They are not single-organization accounts. They represent the structural patterns that appear repeatedly across sectors, scales, and geographies.

Case Study 1: Financial Services

Situation: 250 Applications, Zero Standards

A global financial services firm had been running AI initiatives for three years before a new CAIO was appointed. On her first week, she asked for an inventory of AI applications in production or active development. The list came back at 253 line items.

The problem was not the number. The problem was what was behind it. Before the CAIO role existed, there was no central AI function. Each business unit managed its own vendor relationships, negotiated its own contracts, and requested infrastructure from IT on an ad hoc basis with no shared standards. The result was predictable in retrospect: each item on that list had been built by a different team, using different models, different vendors, different data access patterns, and different governance assumptions. Some were processing customer PII without documented data handling agreements. Several were using the same underlying model from three different vendors at three different price points. Two were solving the same problem independently in adjacent business units with no knowledge of each other.

There was no shared infrastructure. There was no shared evaluation methodology. There was no shared risk framework. The organization had spent three years building AI in every direction simultaneously, with no mechanism for learning to propagate between teams.

The CAIO described it as "253 separate programs, each of which believed it was the AI program."

Before any of this could be addressed, the team tried the obvious path: create shared standards while letting new development continue. It did not work. Teams built faster than standards could be written. By the time a standard was drafted, three new applications had been approved that did not conform to it. The standards process became an academic exercise.

Approach: Portfolio Logic and Shared Infrastructure

The CAIO's first decision was to impose a 90-day pause on new AI initiative approvals. The pause was controversial. It cost momentum and created internal resistance from business units that had active initiatives in flight. It was also the right call.

During the pause, the team conducted a structured portfolio assessment. Each of the 253 applications was evaluated against four criteria: business value delivered, data and governance compliance, technical sustainability, and strategic alignment. The result was a four-category classification: strategic (continue and invest), maintain (operate but do not grow), consolidate (merge with a strategic application), and exit (decommission).

Of the 253 applications: 31 were classified as strategic, 47 as maintain, 88 as candidates for consolidation, and 87 for exit. The exit list included applications that had been running for over a year, some with active users, that had never produced a measurable business outcome. The 87 exits were not failures of technology. They were failures of governance. Teams had lost tools they used daily, and some of the resistance was legitimate: a few of those applications had genuine utility that had simply never been measured.

The exit process was difficult. Business unit leaders defended their applications. The CAIO maintained the criteria and declined to make exceptions. By month six, the portfolio had contracted to 89 applications. By month twelve, a shared model access layer, shared evaluation infrastructure, and a unified intake process were operational. Vendor consolidation, from three overlapping contracts at varying price points to a single negotiated enterprise agreement, generated savings that funded the shared infrastructure build.

Results

• Portfolio reduced from 253 to 89 applications, with governance coverage of 100%
• Shared infrastructure reduced per-application model access cost by 34%
• Time from use case approval to pilot launch reduced from 6 months to 7 weeks
• Vendor consolidation from three contracts to one negotiated enterprise agreement eliminated the cost of redundant access to the same underlying models
• Two consolidation projects surfaced use cases that had been developed independently in different regions; the merged versions outperformed both predecessors

Lessons Learned

An AI inventory is an act of leadership. Knowing what you have requires asking questions that expose uncomfortable answers. Most organizations avoid the inventory because they do not want to know. The ones that succeed do the inventory first.

Portfolio criteria must be non-negotiable. The moment an exception is made for a politically important use case, the criteria become suggestions. Criteria that cannot be enforced are not criteria.

Shared infrastructure is a strategic asset. The cost savings from consolidation were secondary. The primary benefit was the ability to propagate learnings, enforce standards, and move faster on new use cases because the plumbing already existed.

Case Study 2: Manufacturing

Situation: Double-Digit Gains, Zero Balance Sheet Impact

A global manufacturer deployed AI-assisted process optimization and quality control tools across its production network. The deployment was extensive. Within 18 months, 78% of production line supervisors were actively using the tools daily. A third-party evaluation confirmed that individual decision-making quality improved by 22%.

The CFO asked why none of it appeared in the financials.

The CAIO commissioned a workflow study. Three researchers spent four weeks on production floors, in planning meetings, and in shift-handover sessions, observing how the tools were actually being used. The findings were uncomfortable.

The pre-AI operating model had given supervisors full discretion over workflow decisions. AI was overlaid on top of that model without changing job descriptions, performance metrics, or the structure of how decisions got made. When AI surfaced an optimization recommendation, supervisors did not act on it and move to the next task. They spent the recaptured time reviewing the recommendation in more detail, discussing it with colleagues, and documenting their reasoning. When quality control AI flagged fewer defects, the time savings went into more frequent manual spot-checks that had not existed before. The AI created efficiency. The organization filled the efficiency with additional work of similar or lower value.

The first attempt at fixing this was to let supervisors figure out on their own how to use the recaptured time productively. That produced zero measurable impact for six months. Supervisors were not being obstinate. They had no redesigned workflow to follow and no changed performance incentives to point them toward different behavior. Without those, they defaulted to doing more of what they already knew how to do.

Nobody had designed a different workflow. The tools had been deployed into existing workflows and expected to produce savings by acceleration alone. That expectation was wrong.

Approach: Workflow Redesign Before Redeployment

The CAIO worked with operations leadership to pause the performance claims and redesign the workflows around the tools, rather than the tools around the workflows.

For each production function, the team defined: what the AI would handle autonomously, what would require human review, what decisions could be made faster with AI context, and what the recaptured time should be used for. The last question was the hardest. It required operations managers to make deliberate choices about where human attention should go when AI handled lower-value tasks. The redesign also required plant managers to take authority over decisions that had previously been left to supervisor discretion. Some supervisors experienced this as a reduction in autonomy, because it was. That was the tradeoff. Standardizing how recaptured time was used meant reducing the range of choices individual supervisors could make about it.

The redesign process took four months. It required buy-in from plant managers who were being asked to change processes that had worked fine for years. The change management investment was significant.

Results

• After workflow redesign, throughput increased 18% with the same headcount, contributing the largest share of the financial outcome
• Quality escape rate (defects reaching customers) declined 31%, eliminating rework costs and warranty exposure
• Three plants avoided planned headcount additions by absorbing volume growth through AI-augmented throughput
• Balance sheet impact: $14M in avoided costs in the first full year post-redesign, across throughput gains, quality escape reduction, and avoided headcount

Lessons Learned

AI deployed into unchanged workflows does not change financial outcomes. The technology can be excellent and the adoption can be high and the balance sheet can show nothing. Workflow redesign is not optional.

"What should humans do with the time?" is a management question, not a technology question. Technology teams cannot answer it. Operations leadership must own it. Ensure that question is answered before deployment, not after.

The measurement gap is often a workflow gap. If AI is delivering measurable task-level improvements but no financial impact, the most likely explanation is that the efficiency is being consumed by adjacent low-value work. Look at the workflow, not the model.

Case Study 3: Healthcare

Situation: AI as a Mirror for Acquisition Debt

A regional healthcare system had grown significantly through acquisitions over eight years, adding seven hospital networks, four specialty practices, and two outpatient chains. Each acquired facility had operated independently, with its own clinical workflows, documentation standards, and operational processes. No shared standards had been established during any of the acquisitions. The operating model was federated by default, not by design.

When the system attempted to deploy AI-assisted clinical documentation support, the deployment team discovered a problem that had nothing to do with AI. The same clinical task was being executed in dozens of different ways across different facilities. Admission workflows had 23 documented variants. Discharge planning followed eight different protocols. Medication reconciliation had no standard at all.

The team ran a pilot before addressing any of this. The AI deployed into unstandardized workflows achieved 61% accuracy. That result wasted four months and damaged clinician trust at the pilot sites. Clinicians who saw the AI perform poorly in that initial deployment were harder to re-engage once the underlying process work was complete. The cost of piloting before standardizing was not just time. It was credibility.

AI could not be deployed at scale because there was no consistent process to augment. The system would have needed to build dozens of AI variants or accept that the AI would perform well in some facilities and poorly in others.

The CAIO brought this finding to the executive committee and reframed the AI readiness program as a process standardization initiative with AI deployment as the endpoint.

Approach: AI Readiness as a Process Improvement Catalyst

The organization established a Clinical Process Standardization program, co-owned by the CMO and the CAIO. The explicit goal was to define the target-state workflows that AI would then be built to support.

This was not presented as an AI delay. It was presented as the AI program accelerating process work that should have happened during the acquisitions. The AI deployment timeline became the forcing function for decisions that had been deferred for years.

The standardization work proceeded in three tranches, prioritized by clinical impact and AI readiness potential. Each tranche produced a standard workflow, validated with clinical leads from across the network, before AI development began. The validation process surfaced a real tension: some facilities had developed workflow variants that were not arbitrary deviations but legitimate adaptations to regional patient populations or local staffing models. Standardization required overriding some of those adaptations. That was a genuine reduction in local clinical autonomy, and some facilities resisted it on those grounds. The program addressed this by creating explicit exception pathways for documented regional requirements, but the baseline standard held.

Results

• 11 of 23 admission workflow variants consolidated to 3 standard protocols within 9 months
• AI documentation support deployed to consolidated protocols, achieving 94% accuracy compared to 61% in the pre-standardization pilot
• Clinician time savings from AI: average 22 minutes per shift per provider
• Cross-facility patient transfer complications declined 14%, a secondary benefit of standardization that had nothing to do with AI

Lessons Learned

AI readiness reveals organizational debt. The process inconsistencies existed before AI. AI made them visible by making them consequential. Organizations that use AI deployment as a reason to standardize processes will get better AI outcomes and better operational outcomes.

The CAIO cannot own process standardization alone. Clinical, operational, and business process owners must lead the work. The CAIO enables it and sets the AI-readiness timeline as the forcing function. Without clinical leadership ownership, the standardization work stalls.

"AI is not ready" is sometimes "our processes are not ready." This is an uncomfortable message to deliver to leadership. It is also the honest one. The organizations that hear it early and act on it avoid the expensive mistake of deploying AI into inconsistent processes and getting inconsistent results.

Case Study 4: Professional Services

Situation: 170 Countries, Dozens of Ways to Do the Same Thing

A global professional services firm operated across 170 countries through a combination of owned offices and member firm partnerships. Country offices had full delivery autonomy. Each had developed its own delivery methodology, client reporting format, engagement management approach, and quality review process. Quality was managed locally by definition: there was no global quality baseline to measure against. That model had worked adequately before AI, because the variance was distributed and largely invisible to the center.

A new global AI initiative aimed to deploy AI-assisted report drafting, data synthesis, and client communication tools across the network. The pilot in three markets produced strong results. The rollout to thirty markets produced chaos.

The AI performed well where the underlying work process was consistent. It performed poorly where the process was ambiguous, idiosyncratic, or entirely different from what the model had been optimized for. Country leads began customizing the AI outputs to fit local practices. The customizations accumulated. Within six months, the "global" AI tool was a collection of locally modified variants with no shared quality standard. The pre-standardization rollout had measured 67% of outputs as meeting quality standards. The other 33% were a direct reflection of the variation that had always existed, now surfaced and measurable.

The Global Head of Delivery described it as "the same problem we have with our non-AI processes, but faster."

Approach: Standardize Before Scale

The firm paused the rollout at 30 markets and established a Global Delivery Standards program. The CAIO and the Global Head of Delivery co-led it.

The program's scope was deliberately narrow: identify the 20% of delivery processes that represented 80% of AI deployment surface area, and standardize those processes globally before expanding the AI rollout. The remaining 80% of processes, which were lower-value AI targets, were allowed to remain local.

The standards process involved regional leads from all major geographies. Each standard went through three rounds of review before being ratified: a technical review, a regional feasibility review, and a quality assurance review. The process took eight months. Leadership had asked for three. The CAIO's position was that a three-month standard would be rejected in practice by markets that had not been consulted, producing the same outcome as no standard at all. The eight-month timeline held. The tradeoff was real: high-performing markets with strong local practices had to adopt global standards that in some cases were less refined than what they had built independently. That constraint was the point. A global standard that high performers could opt out of is not a standard.

Results

• 14 core delivery processes standardized globally over 8 months
• AI rollout resumed to 170 markets with standardized processes as the deployment foundation
• AI output quality consistency: 91% of outputs rated "meets standard" vs. 67% in the pre-standardization rollout
• Training and onboarding time for new engagement managers reduced by 40%, a process standardization benefit independent of AI; across 170 markets with continuous hiring, the compounding value of that reduction is significant
• Secondary effect: the quality baseline created visibility into market-level delivery variance that had not previously been measurable

Lessons Learned

Scale amplifies inconsistency. A process that works adequately in one context will fail visibly at global scale when AI exposes the variation. AI is a forcing function for standardization in the same way that global expansion is a forcing function for governance.

Do not scale AI before the process is ready to scale. The pressure to demonstrate global AI deployment velocity is real. The cost of deploying AI into inconsistent processes at scale is higher than the cost of taking six months to standardize first.

Regional buy-in is non-negotiable. Global standards imposed from the center without regional co-creation will be adopted on paper and ignored in practice. Co-creation is slower. It produces standards that are actually followed. That is worth the time.